Mid Cap · Financial · Asset Management
Mid Cap · Financial · Asset Management
Get the AI take on CNS
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$60
Median target
$80
Current price
$84.83
Highest
$88
Forward P/E
Needs attention · 37% above avg
22.57x
Price / sales
Reasonable · Priced reasonably against its revenue
7.46x
Price / FCF
Rich · Priced far above what its cash flow currently supports
63.73x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
20.73x
ROIC
Strong · Comfortably clears the bar for efficient capital use
26.1%
ROE
Favorable · 29.1% - strong capital efficiency
27.3%
Debt / equity
Favorable · 0.24 - strong leverage
0.19x
Current ratio
Strong · Comfortable room to cover bills due within a year
6.64x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $4.36B | 26.0 | +7.4% | 52 | |
| $192.11B | 20.2 | +20.3% | 81 | |
| $73.57B | 20.7 | +44.3% | 81 | |
| $11.82B | 17.4 | +45.4% | 79 | |
| $12.71B | 15.4 | +21.4% | 77 |